Nociceptin analogs
US7563809B2 · kind B2 · utility
8Cited by
14References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2005 |
| Grant date | Jul 21, 2009 |
| Priority date | — |
| Expiry date | Mar 1, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to benzothiadiazole compounds of formula (I):and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R1, R2, A, B, C, W, Z and n are defined as set forth in the specification. The compounds of the invention have affinity for the nociceptin receptor. The invention is also directed to the use of compounds of Formula (I) to treat a disorder responsive to modulation of the nociceptin receptor. Compounds of the present invention are especially useful for treating pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.